Why the study?
The mechanism driving brain-specific alternative splicing of MYH9 pre-mRNA to generate the inactive mechanoenzyme NMIIA2 in neuronal cells was unexplored.
Brain-specific alternative splicing of the A2 exon in NMHC IIA is driven by the interaction between a weak 5' splice site and the neuron-specific splice factor RbFox3.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; leaves open validation of neuronal splicing mechanisms in human models.
The brain-specific alternative splicing of MYH9 pre-mRNA causes insertion of a 63-nucleotide exon (21-amino acid, A2) at the loop2 region of motor domain in non-muscle myosin heavy chain IIA (NMHCIIA), generating an inactive mechanoenzyme, NMIIA2. But the mechanism of such a splicing event in a neuronal cell is yet to be explored. Here, we report that the skipping of the A2 exon in non-neuronal cells arises due to the presence of a weak 5' splice site, as increasing the strength of 5' splice site prevents such skipping. The binding of neuron-specific splice factors, RbFox (s), at the 5' splice site overcomes the effect of a weak 5' splice site, leading to the expression of NMIIA2 protein in the neuronal cells. Our findings suggest that the presence of a weak 5' splice site and its interaction with RbFox specify alternative splicing of A2 exon in the neuronal cells.
No takes yet. Share an insight, caveat, or question.
Mallick et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: